A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes

被引:3
|
作者
Lee, Jin-Gu [1 ,2 ]
Fu, Yulong [1 ,4 ]
Zhu, Jun-yi [1 ,2 ]
Wen, Pei [1 ,2 ]
van de Leemput, Joyce [1 ,2 ]
Ray, Patricio E. [3 ]
Han, Zhe [1 ,2 ]
机构
[1] Univ Maryland, Ctr Precis Dis Modeling, Sch Med UMSOM, Dept Med, 670 West Baltimore St,4052 HSFIII, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[3] Univ Virginia, Child Hlth Res Ctr, Sch Med, Dept Pediat, 409 Lane Rd, Charlottesville, VA 22908 USA
[4] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA
关键词
SNARE proteins; SNARE protective pool; APOL1; Renal toxicity; Nephrocytes; Serum resistance-associated (SRA) protein; RISK VARIANTS; KIDNEY-DISEASE; AFRICAN-AMERICANS; GENE; CELL; CYTOTOXICITY; PROTEIN; INJURY;
D O I
10.1186/s13578-023-01147-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background People of Sub-Saharan African ancestry are at higher risk of developing chronic kidney disease (CKD), attributed to the Apolipoprotein L1 (APOL1) gene risk alleles (RA) G1 and G2. The underlying mechanisms by which the APOL1-RA precipitate CKD remain elusive, hindering the development of potential treatments.Results Using a Drosophila genetic modifier screen, we found that SNARE proteins (Syx7, Ykt6, and Syb) play an important role in preventing APOL1 cytotoxicity. Reducing the expression of these SNARE proteins significantly increased APOL1 cytotoxicity in fly nephrocytes, the equivalent of mammalian podocytes, whereas overexpression of Syx7, Ykt6, or Syb attenuated their toxicity in nephrocytes. These SNARE proteins bound to APOL1-G0 with higher affinity than APOL1-G1/G2, and attenuated APOL1-G0 cytotoxicity to a greater extent than either APOL1-RA.Conclusions Using a Drosophila screen, we identified SNARE proteins (Syx7, Ykt6, and Syb) as antagonists of APOL1-induced cytotoxicity by directly binding APOL1. These data uncovered a new potential protective role for certain SNARE proteins in the pathogenesis of APOL1-CKD and provide novel therapeutic targets for APOL1-associated nephropathies.
引用
收藏
页数:14
相关论文
共 39 条
  • [21] APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus
    Chung, Cecilia P.
    Karakoc, Gul
    Dickson, Alyson
    Liu, Ge
    Gamboa, Jorge L.
    Mosley, Jonathan D.
    Cox, Nancy J.
    Kawai, Vivian K.
    LUPUS, 2023, 32 (06) : 763 - 770
  • [22] End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
    Freedman, Barry I.
    Langefeld, Carl D.
    Andringa, Kelly K.
    Croker, Jennifer A.
    Williams, Adrienne H.
    Garner, Neva E.
    Birmingham, Daniel J.
    Hebert, Lee A.
    Hicks, Pamela J.
    Segal, Mark S.
    Edberg, Jeffrey C.
    Brown, Elizabeth E.
    Alarcon, Graciela S.
    Costenbader, Karen H.
    Comeau, Mary E.
    Criswell, Lindsey A.
    Harley, John B.
    James, Judith A.
    Kamen, Diane L.
    Lim, S. Sam
    Merrill, Joan T.
    Sivils, Kathy L.
    Niewold, Timothy B.
    Patel, Neha M.
    Petri, Michelle
    Ramsey-Goldman, Rosalind
    Reveille, John D.
    Salmon, Jane E.
    Tsao, Betty P.
    Gibson, Keisha L.
    Byers, Joyce R.
    Vinnikova, Anna K.
    Lea, Janice P.
    Julian, Bruce A.
    Kimberly, Robert P.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (02) : 390 - 396
  • [23] ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2
    Lee, Hewang
    Roshanravan, Hila
    Wang, Ying
    Okamoto, Koji
    Ryu, Junghwa
    Shrivastav, Shashi
    Qu, Peng
    Kopp, Jeffrey B.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (01) : F140 - F150
  • [24] Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease
    Elizabeth I. Anyaegbu
    Andrey S. Shaw
    Keith A. Hruska
    Sanjay Jain
    Pediatric Nephrology, 2015, 30 : 983 - 989
  • [25] APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation
    Servais, Aude
    Gribouval, Olivier
    Gaillard, Francois
    Antignac, Corinne
    NEPHROLOGIE & THERAPEUTIQUE, 2019, 15 : S85 - S89
  • [26] APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease
    Ma, Lijun
    Langefeld, Carl D.
    Comeau, Mary E.
    Bonomo, Jason A.
    Rocco, Michael V.
    Burkart, John M.
    Divers, Jasmin
    Palmer, Nicholette D.
    Hicks, Pamela J.
    Bowden, Donald W.
    Lea, Janice P.
    Krisher, Jenna O.
    Clay, Margo J.
    Freedman, Barry I.
    KIDNEY INTERNATIONAL, 2016, 90 (02) : 389 - 395
  • [27] Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes
    Zhang, Zhongyang
    Sun, Zeguo
    Fu, Jia
    Lin, Qisheng
    Banu, Khadija
    Chauhan, Kinsuk
    Planoutene, Marina
    Wei, Chengguo
    Salem, Fadi
    Yi, Zhengzi
    Liu, Ruijie
    Cravedi, Paolo
    Cheng, Haoxiang
    Hao, Ke
    O'Connell, Philip J.
    Ishibe, Shuta
    Zhang, Weijia
    Coca, Steven G.
    Gibson, Ian W.
    Colvin, Robert B.
    He, John Cijiang
    Heeger, Peter S.
    Murphy, Barbara
    Menon, Madhav C.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (22)
  • [28] APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection
    Purswani, Murli U.
    Patel, Kunjal
    Winkler, Cheryl A.
    Spector, Stephen A.
    Hazra, Rohan
    Seage, George R., III
    Mofenson, Lynne
    Karalius, Brad
    Scott, Gwendolyn B.
    Van Dyke, Russell B.
    Kopp, Jeffrey B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (01) : 63 - 68
  • [29] Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference
    Newell, K. A.
    Formica, R. N.
    Gill, J. S.
    Schold, J. D.
    Allan, J. S.
    Covington, S. H.
    Wiseman, A. C.
    Chandraker, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (04) : 901 - 911
  • [30] Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1
    Lertdumrongluk, Paungpaga
    Streja, Elani
    Rhee, Connie M.
    Moradi, Hamid
    Chang, Yongen
    Reddy, Uttam
    Tantisattamo, Ekamol
    Kalantar-Zadeh, Kamyar
    Kopp, Jeffrey B.
    CARDIORENAL MEDICINE, 2019, 9 (04) : 212 - 221